![]()
Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (+)-schisandrin B | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RPA2 mRNA] | CTD | PMID:31150632 | (-)-quinic acid | multiple interactions | ISO | RGD:1344829 | 6480464 | [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of RPA2 mRNA | CTD | PMID:21751221 | 1,2-dimethylhydrazine | increases expression | ISO | RGD:734242 | 6480464 | 1, 2-Dimethylhydrazine results in increased expression of RPA2 mRNA | CTD | PMID:22206623 | 17alpha-ethynylestradiol | multiple interactions | ISO | RGD:734242 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPA2 mRNA | CTD | PMID:17942748 | 2,2',4,4'-Tetrabromodiphenyl ether | affects expression | ISO | RGD:734242 | 6480464 | 2 more ... | CTD | PMID:30294300 | 2,3,7,8-tetrachlorodibenzodioxine | multiple interactions | ISO | RGD:734242 | 6480464 | [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of RPA2 mRNA, Tetrachlorodibenzodioxin promotes the reaction [AHR protein binds to RPA2 promoter] | CTD | PMID:17942748, PMID:19654925 | 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of RPA2 mRNA | CTD | PMID:33387578, PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:734242 | 6480464 | Tetrachlorodibenzodioxin affects the expression of RPA2 mRNA | CTD | PMID:21570461 | 2,4-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 4-dinitrotoluene affects the expression of RPA2 mRNA | CTD | PMID:21346803 | 2,6-dinitrotoluene | affects expression | EXP | | 6480464 | 2, 6-dinitrotoluene affects the expression of RPA2 mRNA | CTD | PMID:21346803 | 3,3',5-triiodo-L-thyronine | increases phosphorylation | ISO | RGD:1344829 | 6480464 | Triiodothyronine analog results in increased phosphorylation of RPA2 protein | CTD | PMID:22383522 | 3-isobutyl-1-methyl-7H-xanthine | multiple interactions | ISO | RGD:1344829 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPA2 mRNA | CTD | PMID:28628672 | 3-methylcholanthrene | increases expression | ISO | RGD:734242 | 6480464 | Methylcholanthrene results in increased expression of RPA2 mRNA | CTD | PMID:20713471 | 4-hydroxyphenyl retinamide | increases expression | ISO | RGD:734242 | 6480464 | Fenretinide results in increased expression of RPA2 mRNA | CTD | PMID:28973697 | acetamide | increases expression | EXP | | 6480464 | acetamide results in increased expression of RPA2 mRNA | CTD | PMID:31881176 | acrylamide | increases expression | EXP | | 6480464 | Acrylamide results in increased expression of RPA2 mRNA | CTD | PMID:28959563 | aflatoxin B1 | increases expression | ISO | RGD:1344829 | 6480464 | Aflatoxin B1 results in increased expression of RPA2 mRNA | CTD | PMID:27153756 | ammonium chloride | affects expression | EXP | | 6480464 | Ammonium Chloride affects the expression of RPA2 mRNA | CTD | PMID:16483693 | ammonium chloride | increases expression | EXP | | 6480464 | Ammonium Chloride results in increased expression of RPA2 mRNA | CTD | PMID:12420312 | arsenite(3-) | multiple interactions | ISO | RGD:1344829 | 6480464 | arsenite promotes the reaction [G3BP1 protein binds to RPA2 mRNA] | CTD | PMID:32406909 | artesunate | increases phosphorylation | ISO | RGD:1344829 | 6480464 | Artesunate results in increased phosphorylation of RPA2 protein | CTD | PMID:31664825 | atrazine | decreases expression | ISO | RGD:1344829 | 6480464 | Atrazine results in decreased expression of RPA2 mRNA | CTD | PMID:22378314 | benzo[a]pyrene | decreases expression | ISO | RGD:1344829 | 6480464 | Benzo(a)pyrene results in decreased expression of RPA2 protein | CTD | PMID:20097212 | benzo[a]pyrene | increases expression | ISO | RGD:1344829 | 6480464 | Benzo(a)pyrene results in increased expression of RPA2 mRNA | CTD | PMID:32234424 | benzo[a]pyrene | increases methylation | ISO | RGD:1344829 | 6480464 | Benzo(a)pyrene results in increased methylation of RPA2 promoter | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | ISO | RGD:734242 | 6480464 | Benzo(a)pyrene results in increased expression of RPA2 mRNA | CTD | PMID:21715664, PMID:22228805 | biphenyl-4-amine | increases expression | ISO | RGD:1344829 | 6480464 | 4-biphenylamine results in increased expression of RPA2 mRNA | CTD | PMID:32905825 | biphenyl-4-amine | multiple interactions | ISO | RGD:1344829 | 6480464 | TP53 protein inhibits the reaction [4-biphenylamine results in increased expression of RPA2 mRNA] | CTD | PMID:32905825 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RPA2 mRNA | CTD | PMID:25181051 | bisphenol A | multiple interactions | ISO | RGD:1344829 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RPA2 gene | CTD | PMID:31601247 | bisphenol F | multiple interactions | ISO | RGD:1344829 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPA2 mRNA | CTD | PMID:28628672 | cadmium atom | increases expression | ISO | RGD:734242 | 6480464 | Cadmium results in increased expression of RPA2 mRNA | CTD | PMID:23358151 | cadmium atom | multiple interactions | ISO | RGD:1344829 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPA2 mRNA | CTD | PMID:35301059 | cadmium dichloride | multiple interactions | ISO | RGD:1344829 | 6480464 | [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of RPA2 mRNA | CTD | PMID:35301059 | caffeine | increases phosphorylation | ISO | RGD:1344829 | 6480464 | Caffeine results in increased phosphorylation of RPA2 protein | CTD | PMID:35688186 | calcitriol | multiple interactions | ISO | RGD:1344829 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RPA2 mRNA | CTD | PMID:21592394 | calcitriol | decreases expression | ISO | RGD:1344829 | 6480464 | Calcitriol results in decreased expression of RPA2 mRNA | CTD | PMID:21592394 | carbamazepine | affects expression | ISO | RGD:1344829 | 6480464 | Carbamazepine affects the expression of RPA2 mRNA | CTD | PMID:24752500, PMID:25979313 | carbon nanotube | increases expression | ISO | RGD:734242 | 6480464 | Nanotubes more ... | CTD | PMID:25554681 | cisplatin | increases expression | ISO | RGD:1344829 | 6480464 | Cisplatin results in increased expression of RPA2 mRNA | CTD | PMID:27594783 | copper(II) sulfate | decreases expression | ISO | RGD:1344829 | 6480464 | Copper Sulfate results in decreased expression of RPA2 mRNA | CTD | PMID:19549813 | corticosterone | decreases expression | EXP | | 6480464 | Corticosterone results in decreased expression of RPA2 mRNA | CTD | PMID:15755911 | cyclophosphamide | decreases expression | EXP | | 6480464 | Cyclophosphamide results in decreased expression of RPA2 mRNA | CTD | PMID:11906922 | cyclosporin A | increases expression | ISO | RGD:1344829 | 6480464 | Cyclosporine results in increased expression of RPA2 mRNA | CTD | PMID:20106945 | cyclosporin A | affects expression | ISO | RGD:1344829 | 6480464 | Cyclosporine affects the expression of RPA2 mRNA | CTD | PMID:25562108 | dexamethasone | multiple interactions | ISO | RGD:1344829 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPA2 mRNA | CTD | PMID:28628672 | dibutyl phthalate | decreases expression | ISO | RGD:734242 | 6480464 | Dibutyl Phthalate results in decreased expression of RPA2 mRNA | CTD | PMID:17361019, PMID:21266533 | diclofenac | affects expression | ISO | RGD:1344829 | 6480464 | Diclofenac affects the expression of RPA2 mRNA | CTD | PMID:24752500 | endosulfan | increases expression | EXP | | 6480464 | Endosulfan results in increased expression of RPA2 mRNA | CTD | PMID:29391264 | folic acid | decreases expression | ISO | RGD:734242 | 6480464 | Folic Acid results in decreased expression of RPA2 mRNA | CTD | PMID:25629700 | fulvestrant | multiple interactions | ISO | RGD:1344829 | 6480464 | [bisphenol A co-treated with Fulvestrant] results in decreased methylation of RPA2 gene | CTD | PMID:31601247 | glyphosate | decreases expression | ISO | RGD:1344829 | 6480464 | glyphosate results in decreased expression of RPA2 mRNA | CTD | PMID:31295307 | hydrogen peroxide | multiple interactions | ISO | RGD:1344829 | 6480464 | [Hydrogen Peroxide co-treated with Quinic Acid analog] results in increased expression of RPA2 mRNA | CTD | PMID:21751221 | indometacin | multiple interactions | ISO | RGD:1344829 | 6480464 | [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of RPA2 mRNA | CTD | PMID:28628672 | ivermectin | decreases expression | ISO | RGD:1344829 | 6480464 | Ivermectin results in decreased expression of RPA2 protein | CTD | PMID:32959892 | leflunomide | decreases expression | ISO | RGD:1344829 | 6480464 | leflunomide results in decreased expression of RPA2 mRNA | CTD | PMID:28988120 | methyl methanesulfonate | increases expression | ISO | RGD:1344829 | 6480464 | Methyl Methanesulfonate results in increased expression of RPA2 mRNA | CTD | PMID:23649840 | methylseleninic acid | decreases expression | ISO | RGD:1344829 | 6480464 | methylselenic acid results in decreased expression of RPA2 mRNA | CTD | PMID:12517777 | N-(6-acetamidohexyl)acetamide | decreases expression | ISO | RGD:734242 | 6480464 | hexamethylene bisacetamide results in decreased expression of RPA2 mRNA | CTD | PMID:26941288 | nickel atom | decreases expression | ISO | RGD:1344829 | 6480464 | Nickel results in decreased expression of RPA2 mRNA | CTD | PMID:23195993 | oxaliplatin | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RPA2 mRNA | CTD | PMID:25729387 | ozone | increases expression | EXP | | 6480464 | Ozone results in increased expression of RPA2 mRNA | CTD | PMID:16330353 | ozone | multiple interactions | ISO | RGD:734242 | 6480464 | [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of RPA2 mRNA | CTD | PMID:34911549 | paracetamol | affects expression | ISO | RGD:734242 | 6480464 | Acetaminophen affects the expression of RPA2 mRNA | CTD | PMID:17562736 | paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of RPA2 mRNA | CTD | PMID:33387578 | paracetamol | increases expression | ISO | RGD:1344829 | 6480464 | Acetaminophen results in increased expression of RPA2 mRNA | CTD | PMID:22230336 | phenobarbital | increases expression | ISO | RGD:734242 | 6480464 | Phenobarbital results in increased expression of RPA2 mRNA | CTD | PMID:23091169 | picoxystrobin | increases expression | ISO | RGD:1344829 | 6480464 | picoxystrobin results in increased expression of RPA2 mRNA | CTD | PMID:33512557 | pirinixic acid | multiple interactions | ISO | RGD:734242 | 6480464 | [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of RPA2 mRNA, PPARA protein promotes the reaction [pirinixic acid results in increased expression of RPA2 mRNA] | CTD | PMID:17950772, PMID:19710929 | pirinixic acid | increases expression | ISO | RGD:734242 | 6480464 | pirinixic acid results in increased expression of RPA2 mRNA | CTD | PMID:17950772 more ... | pirinixic acid | increases expression | EXP | | 6480464 | pirinixic acid results in increased expression of RPA2 mRNA | CTD | PMID:19162173 | piroxicam | decreases expression | ISO | RGD:1344829 | 6480464 | Piroxicam results in decreased expression of RPA2 mRNA | CTD | PMID:21858171 | progesterone | decreases expression | EXP | | 6480464 | Progesterone results in decreased expression of RPA2 mRNA | CTD | PMID:20726854 | quizartinib | multiple interactions | ISO | RGD:1344829 | 6480464 | quizartinib affects the reaction [RGFP966 results in increased phosphorylation of RPA2 protein], RGFP966 affects the reaction [quizartinib results in increased phosphorylation of RPA2 protein] | CTD | PMID:34665271 | quizartinib | increases phosphorylation | ISO | RGD:1344829 | 6480464 | quizartinib results in increased phosphorylation of RPA2 protein | CTD | PMID:34665271 | resveratrol | increases expression | ISO | RGD:734242 | 6480464 | resveratrol results in increased expression of RPA2 protein | CTD | PMID:25505154 | sodium arsenite | increases expression | ISO | RGD:1344829 | 6480464 | sodium arsenite results in increased expression of RPA2 mRNA | CTD | PMID:34032870 | sodium dichromate | increases expression | EXP | | 6480464 | sodium bichromate results in increased expression of RPA2 mRNA | CTD | PMID:12325037 more ... | Soman | decreases expression | EXP | | 6480464 | Soman results in decreased expression of RPA2 mRNA | CTD | PMID:19281266 | testosterone | multiple interactions | ISO | RGD:1344829 | 6480464 | [Testosterone co-treated with Calcitriol] results in decreased expression of RPA2 mRNA | CTD | PMID:21592394 | testosterone | decreases expression | ISO | RGD:1344829 | 6480464 | Testosterone results in decreased expression of RPA2 mRNA | CTD | PMID:21592394 | tetrachloromethane | affects expression | ISO | RGD:734242 | 6480464 | Carbon Tetrachloride affects the expression of RPA2 mRNA | CTD | PMID:17484886 | tetrachloromethane | increases expression | ISO | RGD:734242 | 6480464 | Carbon Tetrachloride results in increased expression of RPA2 mRNA | CTD | PMID:31919559 | tetrachloromethane | multiple interactions | EXP | | 6480464 | schizandrin B inhibits the reaction [Carbon Tetrachloride results in increased expression of RPA2 mRNA] | CTD | PMID:31150632 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of RPA2 mRNA | CTD | PMID:31150632 | tetrahydropalmatine | decreases expression | ISO | RGD:1344829 | 6480464 | tetrahydropalmatine results in decreased expression of RPA2 protein | CTD | PMID:20109541 | thioacetamide | increases expression | EXP | | 6480464 | Thioacetamide results in increased expression of RPA2 mRNA | CTD | PMID:23411599, PMID:34492290 | topotecan | multiple interactions | EXP | | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RPA2 mRNA | CTD | PMID:25729387 | trimellitic anhydride | increases expression | ISO | RGD:734242 | 6480464 | trimellitic anhydride results in increased expression of RPA2 mRNA | CTD | PMID:19042947 | troglitazone | decreases expression | ISO | RGD:1344829 | 6480464 | troglitazone results in decreased expression of RPA2 mRNA | CTD | PMID:19140230 | valproic acid | decreases expression | ISO | RGD:734242 | 6480464 | Valproic Acid results in decreased expression of RPA2 mRNA | CTD | PMID:21427059 | veliparib | multiple interactions | ISO | RGD:1344829 | 6480464 | veliparib inhibits the reaction [PARP1 protein mutant form results in increased expression of RPA2 protein modified form] | CTD | PMID:27694308 | zinc atom | decreases expression | ISO | RGD:1344829 | 6480464 | Zinc deficiency results in decreased expression of RPA2 mRNA | CTD | PMID:22171008 | zinc(0) | decreases expression | ISO | RGD:1344829 | 6480464 | Zinc deficiency results in decreased expression of RPA2 mRNA | CTD | PMID:22171008 | |